Lee Schacter joins Clinipace
This article was originally published in Scrip
Clinipace, a global digital contract research organization (dCRO), has named Dr Lee Schacter executive medical director, oncology. Dr Schacter will provide strategic guidance, program design, and medical oversight to clients conducting oncology development programs. Prior to joining Morrisville, North Carolina-based Clinipace, Dr Schacter was an independent consultant with Phasen Consulting, during which time he was CMO of the Multiple Myeloma Research Foundation, worked with Janssen R&D, and was medical director for marketed oncology products at AstraZeneca.